Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...

The following was adapted and updated from a set of prepared remarks initially prepared by the author and delivered at the ...

The ACA undoubtedly made health insurance more affordable for consumers of limited means. However, premium subsidies and ...

CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost ...

Health Affairs' Jeff Byers welcomes Deputy Editor Chris Fleming and Katie Keith of Georgetown Law to the program to discuss ...

Premiums and deductibles have risen much more rapidly than its creators projected, and throwing more money at the program has ...

The ACA has touched the lives of every American, proving that improving the U.S. health system is possible. It can, and ...

A new Executive Order refocuses federal agency attention on making already-required price data easier to get and use – a ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers ...

Specific changes are needed to lower the barriers to entry for using the hospital and insurer price transparency data, ...

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...